Actualités Pharming Group NV - PHAR | Actions NASDAQ

Outils de qualité professionnelle, pour des investisseurs individuels.

Pharming Group to report second quarter and first half 2023 financial results on August 3

Pharming Group to report second quarter and first half 2023 financial results on August 3 PR Newswire LEIDEN...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 6-KREPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR...

Pharming announces sale of priority review voucher

Pharming announces sale of priority review voucher PR Newswire LEIDEN, The Netherlands, June 1, 2023 LEIDEN...

Pharming Group to attend the following Investor Conferences in June

Pharming Group to attend the following Investor Conferences in June PR Newswire LEIDEN, The Netherlands, May...

Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders

Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders PR Newswire LEIDEN, The Netherlands, May 17, 2023 LEIDEN...

Pharming Group reports financial results for the first quarter of 2023

Pharming Group reports financial results for the first quarter of 2023 PR Newswire LEIDEN, Netherlands, May...

Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023

Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023 PR Newswire LEIDEN, Netherlands...

Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023

Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023 PR Newswire LEIDEN, Netherlands...

Notice of First Quarter 2023 Results

Notice of First Quarter 2023 Results PR Newswire LEIDEN, Netherlands, April 19, 2023 LEIDEN, Netherlands...

Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023

Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023 PR Newswire LEIDEN...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 6-KREPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR...

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S. PR...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Pharming Group NV (PHAR)

Outils de qualité professionnelle, pour des investisseurs individuels.

PHAR Actualités

Pharming Group to report second quarter and first half 2023 financial results on August 3

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Pharming announces sale of priority review voucher

Pharming Group to attend the following Investor Conferences in June

Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders

Pharming Group reports financial results for the first quarter of 2023

Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023

Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023

Notice of First Quarter 2023 Results

Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Pharming Group NV (PHAR) Actualités

Pharming Group NV (PHAR)

Outils de qualité professionnelle, pour des investisseurs individuels.

PHAR Actualités

Pharming Group to report second quarter and first half 2023 financial results on August 3

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Pharming announces sale of priority review voucher

Pharming Group to attend the following Investor Conferences in June

Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders

Pharming Group reports financial results for the first quarter of 2023

Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023

Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023

Notice of First Quarter 2023 Results

Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application